EDGE Experience Diligence Guidance Execution


EDGE Commercial Awarded Leasing for Biomed Research Center at Shady Grove

Bethesda, Maryland, July 15, 2008 – EDGE BIOReal Estate, the life science division of EDGE Commercial headed by Melvin D. Booth, Chairman, announced today that it has been retained by BioMed Realty Trust, Inc. (NYSE: BMR) as exclusive leasing representative for the proposed development of BioMed Research Center at Shady Grove in Rockville, Maryland. This engagement brings EDGE’S leasing and management portfolio to over 5 million square feet.

“We are excited to have the opportunity to develop a world class life science research and development park in a market as dynamic as Maryland’s I-270 Corridor. We are also pleased to be able to work with EDGE BIOReal Estate on a project of this magnitude. Their unique team brings together executive-level life sciences and real estate experience that is unparalleled within the market. Together, we will deliver a world class development that will help to grow and foster the life science community in this internationally-renowned research and development hub.”

– Matthew G. McDevitt, Executive Vice President of BioMed

BioMed intends to develop BioMed Research Center at Shady Grove on approximately 18 acres in the heart of Montgomery County’s I-270 Technology Corridor, which is immediately adjacent to the BioMed owned corporate headquarters of Human Genome Sciences. BioMed estimates that the project will comprise up to 525,000 square feet of “Class A” laboratory, R&D and office space. BioMed and EDGE are currently working with Montgomery County officials to determine the final site design.

Posted in General